Robin Guo
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Oncology 14
- Peptidase Inhibition and Analysis 4
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Alexander Drilon (10 shared papers)Natasha Rekhtman (5 shared papers)Jason C. Chang (4 shared papers)Maria E. Arcila (4 shared papers)Jia Luo (2 shared papers)Mark G. Kris (9 shared papers)Lufen Chang (3 shared papers)Yun Yen (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Thoracic Oncology (5 papers)Annals of Oncology (3 papers)JCO Precision Oncology (2 papers)Gynecologic Oncology (2 papers)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Robin Guo
27 papers receiving 636 citations
Peers
Comparison fields: 5 of 63
- Hepatology 111
- Pulmonary and Respiratory Medicine 289
- Oncology 189
- Cancer Research 89
- Geriatrics and Gerontology 14
Countries citing papers authored by Robin Guo
This map shows the geographic impact of Robin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Guo more than expected).
Fields of papers citing papers by Robin Guo
This network shows the impact of papers produced by Robin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Guo. The network helps show where Robin Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 218 | |
| 2 | 2019 | 122 | |
| 3 | 2008 | 57 | |
| 4 | 2019 | 35 | |
| 5 | 2019 | 26 | |
| 6 | 2013 | 23 | |
| 7 | 2019 | 22 | |
| 8 | 2019 | 21 | |
| 9 | 2020 | 19 | |
| 10 | 2021 | 19 | |
| 11 | 2017 | 16 | |
| 12 | 2022 | 15 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2011 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2020 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2023 | 2 |
About Robin Guo
Robin Guo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 30 papers that have together received 643 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Chromatin Remodeling and Cancer (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer-related Molecular Pathways (3 papers), Mechanisms of cancer metastasis (3 papers) and Endometriosis Research and Treatment (2 papers). The work is most often cited by research in Hepatology (111 citations), Pulmonary and Respiratory Medicine (289 citations), Oncology (189 citations), Cancer Research (89 citations) and Geriatrics and Gerontology (14 citations). Robin Guo has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Alexander Drilon, Natasha Rekhtman, Jason C. Chang, Maria E. Arcila, Jia Luo, Mark G. Kris, Lufen Chang, Yun Yen, Jamie Sheren and David J. Kwiatkowski. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, JCO Precision Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.